TDO2 and malignant colon neoplasm: In a mouse colon cancer model, TDO expression significantly enhanced liver metastasis, primarily by inducing AHR-mediated PD-L1 transactivation, which suppressed the immune response and promoted liver metastasis of colon cancer.